Daptomycin antibiotic lock therapy in a rat model of staphylococcal Central venous catheter biofilm infections

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 9, 2011, Pages 4081-4089

  Van Praagh, Andrew D G ^a,b   Li, Tongchuan ^a   Zhang, Shuxin ^a   Arya, Anu ^a   Chen, Liping ^a,c   Zhang, Xi Xian ^a   Bertolami, Shellie ^a   Mortin, Lawrence I ^a  

^a CUBIST PHARMACEUTICALS INC   (United States)

^b CARESTREAM HEALTH INC   (United States)

^c Cardinal Intellectual Property Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC LOCK THERAPY; ANTIBIOTIC THERAPY; ARTICLE; BIOFILM; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; ERADICATION THERAPY; IN VIVO STUDY; INFECTION PREVENTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CATHETERIZATION, CENTRAL VENOUS; DAPTOMYCIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; RATS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 80051808226     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00147-11     Document Type: Article

References (49)

1. Bagnall-Reeb, H. 2004. Evidence for the use of the antibiotic lock technique. J. Infus. Nurs. 27:118-122. (Pubitemid 38380900)
2. Bestul, M B, and H L Vandenbussche. 2005. Antibiotic lock technique: Review of the literature. Pharmacotherapy 25:211-227. (Pubitemid 40223482)
3. Bleyer, A J 2007. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin. J. Am. Soc. Nephrol. 2:1073-1078.
4. Bookstaver, P B, J C Williamson, B K Tucker, I I Raad, and R J Sherertz. 2009. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann. Pharmacother. 43:210-219.
5. Burton, D C, J R Edwards, T C Horan, J A Jernigan, and S K Fridkin. 2009. Methicillin-resistant Staphylococcus aureus central-line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 301:727-736.
6. Capdevila, J A, et al. 2001. Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin. Microbiol. Infect. 7:206-212. (Pubitemid 34966119)
7. Christensen, G D, et al. 1985. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22:996-1006. (Pubitemid 16222727)
8. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - 8th ed. CLSI document M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Cunha, B A, L E Eisenstein, and N S Hamid. 2006. Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: Cure with prolonged/high-dose daptomycin without toxicity. Heart Lung 35:207-211.
10. Cunha, B A, N. Hamid, H. Kessler, and S. Parchuri. 2005. Daptomycin cure after cefazolin treatment failure of methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line. Heart Lung 34:442-447. (Pubitemid 41735291)
11. Cuntz, D., et al. 2002. Local antibiotic lock for the treatment of infections related to central catheters in parenteral nutrition in children. J. Parenter. Enteral Nutr. 26:104-108. (Pubitemid 34163553)
12. Curtin, J., M. Cormican, G. Fleming, J. Keelehan, and E. Colleran. 2003. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob. Agents Chemother. 47:3145-3148. (Pubitemid 37229570)
13. Dimick, J B, et al. 2001. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch. Surg. 136:229-234. (Pubitemid 32143849)
14. Easom, A. 2000. Prophylactic antibiotic lock therapy for hemodialysis catheters. Nephrol. Nurs. J. 27:75.
15. Edmiston, C E, Jr., et al. 2006. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. Am. J. Surg. 192:344-354.
16. Evans, R C, and C J Holmes. 1987. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob. Agents Chemother. 31:889-894. (Pubitemid 17084045)
17. Fernandez-Hidalgo, N., B. Almirante, R. Calleja, I. Ruiz, and A M Planes. 2006. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: Results of an open, non-comparative study. J. Antimicrob. Chemother. 57:1172-1180. (Pubitemid 44644422)
18. Grau, S., M J Gil, J. Mateu-de Antonio, M. Pera, and M. Marin-Casino. 2009. Antibiotic-lock technique using daptomycin for subcutaneous injection ports in a patient on home parenteral nutrition. J. Infect. 59:298-299.
19. Guimard, T., et al. 2010. Failure of antibiotic-lock technique using daptomycin for subcutaneous injection ports in a patient on home parenteral nutrition. J. Infect. 60:505-507.
20. Hachem, R Y, H A Hanna, T. Dvorak, R F Chemaly, and I. Raad. 2005. Activity of daptomycin and tigecycline against clinical isolates causing catheter-related methicillin-resistant Staphylococcus aureus (CR-MRSA) embedded in biofilm, abstr. E-809. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother., Washington, DC. American Society for Microbiology, Washington, DC.
21. Heinzelmann, M., et al. 1997. Phagocytosis and oxidative-burst response of planktonic Staphylococcus epidermidis RP62A and its non-slime-producing variant in human neutrophils. Clin. Diagn. Lab. Immunol. 4:705-710. (Pubitemid 27501410)
22. Johnson, D C, F L Johnson, and S. Goldman. 1994. Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr. Infect. Dis. J. 13:930-931. (Pubitemid 24322793)
23. Kim, S H, et al. 2006. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: A prospective, randomized clinical trial. Kidney Int. 69:161-164. (Pubitemid 43117753)
24. King, A, and I. Phillips. 2001. The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates. J. Antimicrob. Chemother. 48:219-223. (Pubitemid 32755282)
25. Krishnasami, Z., et al. 2002. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 61:1136-1142. (Pubitemid 34175482)
26. Krzywda, E A, D A Andris, C E Edmiston, Jr., and E J Quebbeman. 1995. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect. Control Hosp. Epidemiol. 16:596-598.
27. Laplante, K L, and L A Mermel. 2007. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol. Dial. Transplant. 22:2239-2246.
28. Lee, J-Y, K S Ko, K R Peck, W S Oh, and J-H Song. 2006. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J. Antimicrob. Chemother. 57:1110-1115. (Pubitemid 44644412)
29. Mascio, C T M, J D Alder, and J A Silverman. 2007. Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob. Agents Chemother. 51:4255-4260. (Pubitemid 350209874)
30. Mermel, L A, et al. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1-45.
31. Messing, B., S. Peitra-Cohen, A. Debure, M. Beliah, and J J Bernier. 1988. Antibiotic-lock technique: A new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. J. Parenter. Enteral Nutr. 12:185-189. (Pubitemid 18087294)
32. Mortin, L I, et al. 2007. Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria. Antimicrob. Agents Chemother. 51:1787-1794. (Pubitemid 46744159)
33. Peters, G., R. Locci, and G. Pulverer. 1982. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J. Infect. Dis. 146:479-482. (Pubitemid 12004446)
34. Petersen, P J, et al. 2002. In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant grampositive pathogens. Antimicrob. Agents Chemother. 46:2595-2601. (Pubitemid 34793469)
35. Pfaller, M A, H S Sader, and R N Jones. 2007. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005). Diagn. Microbiol. Infect. Dis. 57:459-465. (Pubitemid 46498660)
36. Pittet, D., D. Tarara, and R P Wenzel. 1994. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598-1601.
37. Poole, C V, D. Carlton, L. Bimbo, and M. Allon. 2004. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: Effect of bacterial pathogen. Nephrol. Dial. Transplant. 19:1237-1244. (Pubitemid 38628145)
38. Raad, I., et al. 2007. Comparative activity of daptomycin, linezolid and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob. Agents Chemother. 51:1656-1660. (Pubitemid 46744141)
39. Rupp, M E, and G L Archer. 1994. Coagulase-negative staphylococci: Pathogens associated with medical progress. Clin. Infect. Dis. 19:231-243.
40. Safdar, N, and D G Maki. 2006. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: A meta-analysis of prospective, randomized trials. Clin. Infect. Dis. 43:474-484. (Pubitemid 44157156)
41. Saginur, R., et al. 2006. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob. Agents Chemother. 50:55-61. (Pubitemid 43042902)
42. Sanchez-Munoz, A., et al. 2005. Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters. Eur. J. Clin. Microbiol. Infect. Dis. 24:291-293. (Pubitemid 40768502)
43. Segarra-Newnham, M, and E M Martin-Cooper. 2005. Antibiotic lock technique: A review of the literature. Ann. Pharmacother. 39:311-318. (Pubitemid 40165222)
44. Steward, P S, W M Davison, and J N Steenbergen. 2009. Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother. 53:3505-3507.
45. Ulphani, J S, and M E Rupp. 1999. Model of Staphylococcus aureus central venous catheter-associated infection in rats. Lab. Anim. Sci. 49:283-287. (Pubitemid 29284383)
46. U.S. Pharmacopeia and National Formulary. 2006. ⟨851⟩ Spectrophotometry and light scattering, p. 2770-2775. ⟨791⟩ pH, p. 2730-2731. Heparin sodium assay, p. 1047-1048. (USP29-NF24). U.S. Pharmacopeia and National Formulary, Rockville, MD.
47. Viale, P., et al. 2003. Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J. Chemother. 15:152-156. (Pubitemid 36609752)
48. Wiederhold, N P, E A Coyle, I I Raad, R A Prince, and R E Lewis. 2005. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J. Antimicrob. Chemother. 55:792-795. (Pubitemid 40691865)
49. Yahav, D., et al. 2008. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: Systematic review and meta-analysis of randomized, controlled trials. Clin. Infect. Dis. 47:83-93. (Pubitemid 351920592)